The world of finance, connected.EN / Global
Zy
CompanyCompany profileReviewed 2026-10-23

Zymeworks Inc.

Zymeworks Inc. is a publicly held biotechnology company based in Vancouver,

Sources and references ↗
COMPANY PROFILE / 10 SOURCE-LINKED FIELDS

Basic company information

Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.

Business sectors
pharmaceutical industry [1]
Company / filing name
Zymeworks Inc. [2]
Headquarters location
Vancouver [1]
Founded
2003 [1]
Legal form
Delaware corporation [1]
Official website
www.zymeworks.com ↗ [1]
ISIN (reported securities)
US98985Y1082 [1]
CIK
1937653 [2]
Country in background record
Canada [1]
Symbols / exchanges
ZYME (Nasdaq) [2]

Company positioning and business

Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, [3]

British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million. This was the largest Canadian biotech IPO in more than a decade. By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange. [3]

In May 2019, Zymeworks announced that GSK has expanded its 2016 licensing and collaboration agreement for the research, development and commercialization of bispecific antibodies across multiple disease areas. The extended agreement has meant that GSK can have access to Zymeworks' heavy-light chain pairing technology, which enables the development of bispecific and multifunctional therapeutics. [3]

Background text: Wikipedia contributors, Zymeworks. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.

Financial year, securities and disclosures

Listed securities: ZYME (Nasdaq). Multiple symbols may represent different share classes or securities of the same registrant. [2]

History and key events

  1. Founding / inception date recorded in Wikidata. [1]

Financial results and regulatory disclosures

No individual financial documents have been indexed yet. Open the source to consult company disclosures. [2]

Related entities and concepts

Frequently asked questions

When was Zymeworks Inc. founded?

Founded: 2003. The linked source provides the background record. [1]

Where is the headquarters of Zymeworks Inc.?

Headquarters location: Vancouver. The linked source provides the background record. [1]

Which business sectors are recorded for Zymeworks Inc.?

Business sectors: pharmaceutical industry. The linked source provides the background record. [1]

Sources and review dates

  1. Wikidata — company background record (CC0) ↗
  2. Company identity and profile data ↗
  3. Wikipedia contributors — Zymeworks (CC BY-SA 4.0) ↗

Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.

Content preparation: source-based compilation with AI assistance. See methods and attribution. Named sources identify the underlying records; no individual expert review is claimed.